Mexidol (
MD
, 2-ethyl-6-methyl-3-hydroxypyridine) is a registered therapeutic agent for the treatment of anxiety disorders. The chemical structure suggests that
MD
may also act as an antioxidant. In this study, the hydroperoxyl radical scavenging activity of
MD
was studied to establish baseline antioxidant activity, followed by an investigation of the effect of
MD
on the copper-catalysed oxidative damage in biological systems, using computational methods. It was found that
MD
exhibits moderate radical scavenging activity against HOO
•
in water and pentyl ethanoate solvents following the single electron transfer and formal hydrogen transfer mechanisms, respectively.
MD
can chelate Cu(II), forming complexes that are much harder to reduce than free Cu(II):
MD
chelation completely quenches the Cu(II) reduction by ascorbic acid and suppresses the rate of reduction reaction by
O
2
⋅
−
that are the main reductants of Cu(II) in biological environments. Therefore,
MD
exerts its anti-HO
•
activity primarily as an OIL-1 inhibitor.